APC and Miyoshi myopathy: Despite solid preclinical evidence about the immunomodulatory role of the Wnt/β-catenin pathway, little is known about the association of genetic aberrations in the APC and CTNNB1 genes with response to immunotherapies and prognosis in patients with MM [13].